408 related articles for article (PubMed ID: 32485534)
21. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
23. Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies.
Manzoor S; Petreni A; Raza MK; Supuran CT; Hoda N
Bioorg Med Chem Lett; 2021 Sep; 48():128249. PubMed ID: 34237441
[TBL] [Abstract][Full Text] [Related]
24. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
[TBL] [Abstract][Full Text] [Related]
25. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights.
Abo-Ashour MF; Eldehna WM; Nocentini A; Bonardi A; Bua S; Ibrahim HS; Elaasser MM; Kryštof V; Jorda R; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2019 Dec; 184():111768. PubMed ID: 31629164
[TBL] [Abstract][Full Text] [Related]
26. 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies.
Alkhaldi AAM; Al-Sanea MM; Nocentini A; Eldehna WM; Elsayed ZM; Bonardi A; Abo-Ashour MF; El-Damasy AK; Abdel-Maksoud MS; Al-Warhi T; Gratteri P; Abdel-Aziz HA; Supuran CT; El-Haggar R
Eur J Med Chem; 2020 Dec; 207():112745. PubMed ID: 32877804
[TBL] [Abstract][Full Text] [Related]
27. Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes.
Sharma V; Kumar R; Angeli A; Supuran CT; Sharma PK
Eur J Med Chem; 2020 May; 193():112219. PubMed ID: 32203788
[TBL] [Abstract][Full Text] [Related]
28. Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.
An R; Lin B; Zhao S; Cao C; Wang Y; Cheng X; Liu Y; Guo M; Xu H; Wang Y; Hou Z; Guo C
Bioorg Chem; 2020 Nov; 104():104347. PubMed ID: 33142414
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives.
Abdel-Aziz AA; El-Azab AS; Bua S; Nocentini A; Abu El-Enin MA; Alanazi MM; AlSaif NA; Hefnawy MM; Supuran CT
Bioorg Chem; 2019 Jun; 87():425-431. PubMed ID: 30921744
[TBL] [Abstract][Full Text] [Related]
31. New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies.
Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Berrino E; Abdelsamie AS; El Diwani HI; Supuran CT
Bioorg Med Chem; 2020 Mar; 28(5):115329. PubMed ID: 32007388
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of 3-benzenesulfonamide-linked 3-hydrazinoisatin derivatives as carbonic anhydrase inhibitors.
Swain B; Marde VS; Singh P; Angeli A; Khan A; Yaddanapudi VM; Ullah Q; Supuran CT; Arifuddin M
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300718. PubMed ID: 38466120
[TBL] [Abstract][Full Text] [Related]
33. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors.
Gul HI; Yamali C; Sakagami H; Angeli A; Leitans J; Kazaks A; Tars K; Ozgun DO; Supuran CT
Bioorg Chem; 2018 Apr; 77():411-419. PubMed ID: 29427856
[TBL] [Abstract][Full Text] [Related]
34. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
Eldehna WM; Abo-Ashour MF; Nocentini A; Gratteri P; Eissa IH; Fares M; Ismael OE; Ghabbour HA; Elaasser MM; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2017 Oct; 139():250-262. PubMed ID: 28802125
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors.
Al-Wahaibi LH; Youssif BGM; Taher ES; Abdelazeem AH; Abdelhamid AA; Marzouk AA
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443307
[TBL] [Abstract][Full Text] [Related]
37. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
[TBL] [Abstract][Full Text] [Related]
38. Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation.
Elimam DM; Elgazar AA; Bonardi A; Abdelfadil M; Nocentini A; El-Domany RA; Abdel-Aziz HA; Badria FA; Supuran CT; Eldehna WM
Eur J Med Chem; 2021 Dec; 225():113800. PubMed ID: 34482273
[TBL] [Abstract][Full Text] [Related]
39. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
[TBL] [Abstract][Full Text] [Related]
40. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
